Indefinite Delivery Contract SPE2DX15D4007

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The IDC, valued at up to $4,999,999.00, has an ultimate completion date of December 31, 2025 and was awarded on March 10, 2015 without any set-aside requirements. The contract provides for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The task orders issued under this IDC cover various medications, devices, and other medical commodities across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. The place of performance for the task orders is primarily Chesterbrook, Pennsylvania. This comprehensive IDC serves as a key vehicle for the DLA to efficiently procure essential pharmaceutical and medical items required by military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

The parent company of the prime contractor, Cencora, Inc., doing business as Amerisourcebergen, is also a significant supplier of pharmaceutical products and medical supplies to the federal government. Cencora, Inc. holds a separate, larger IDC with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This additional IDC further demonstrates Amerisourcebergen's critical role in supporting the pharmaceutical and medical supply needs of the Department of Defense and other government healthcare programs.